Laboratory Procedures. The Contractor agrees to restrict its laboratory provider network to entities having either a CLIA certificate of registration or a CLIA certificate of waiver.
Laboratory Procedures. The laboratory utilized for blood and urine testing will be designated by the Employer after a recommendation of the OPBA prior to March 1, of each calendar year in which testing is to take place. The laboratory must have a current certification that it meets College of American Pathologists’ Forensic Drug Testing Accreditation standards as well as proof that it is operating with Department of Health and Human Services/Substance abuse and Mental Health Services Administration (SAMHSA) certification. Strict chain of custody procedures must be followed for all samples as set by NIDA. The Employer and the OPBA agree that security of submitted biological samples is such a paramount issue that any breach of the chain of custody or apparent tampering with sample integrity results immediately in an invalid sample that may not be used for any purposes. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientifically acceptable preservation manner as established by NIDA. All positive confirmed samples and related paperwork must be retained by the laboratory for at least one year or for the duration of any grievance, disciplinary action, or legal proceedings regarding the sample, whichever is longer. At the conclusion of said period, the sample is to be destroyed along with laboratory maintained paperwork. The laboratory is authorized to test only for the following drugs or classes of drugs: marijuana metabolites, cocaine metabolites, opiate metabolites, Phencyclidine, and amphetamines. The laboratory shall test only for these substances within the limits of initial and confirmation tests as currently defined by DHHS/SAMHSA. Initial testing will consist of a preliminary immunoassay (EMIT Screen). If initial testing results are negative, testing shall be discontinued. Under this Agreement, the following cutoff levels shall be used in determining test results as positive or negative:
Laboratory Procedures a. An employee of the testing laboratory shall remove the sealed plastic bag from the refrigerator at the collection facility, verify the integrity of the bag and transport the sealed plastic bag to the testing laboratory, where the date, time, name and signature of the receiving person is entered on the chain of custody record. Laboratories must comply with applicable provisions of any Federal and State licensing requirements. Accredited laboratories must have the facility and capability, onsite, of performing screening and confirmation tests for each drug or metabolite for which service is offered and requested. The testing laboratory shall maintain a chain of custody record of any individual handling or testing an Employee's specimen.
Laboratory Procedures. Drug testing laboratories shall be secured at all times and shall have in place sufficient security measures to control access to the premises and to ensure that no unauthorized personnel handle the specimens or gain access to the laboratory process or have access to where records are stored. Laboratories shall use chain of custody procedures to maintain control and accountability of specimens from receipt through completion of testing, reporting of results during storage, and continuing until final disposition of specimens. The date and purpose shall be documented on an appropriate Chain of Custody Form each time a specimen is handled or transferred and every individual in the chain shall be identified. Accordingly, authorized technicians shall be responsible for each urine specimen or aliquot in their possession and shall sign and complete Chain of Custody Forms for those specimens or aliquots as they are received.
Laboratory Procedures a. Drug testing laboratories shall be secured at all times and shall have in place sufficient security measures to control access to the premises and to ensure that no unauthorized personnel handle the specimens or gain access to the laboratory process or have access to where records are stored.
Laboratory Procedures. Every batch shall contain an appropriate number of standards for calibrating the instrumentation and a minimum of 10 percent controls. Both quality control and blind performance test samples shall appear as ordinary samples to laboratory analysis.
Laboratory Procedures for the analyses of aqueous and sediment toxicity of samples from freshwater estuarine and marine environments. County hereby engages Contractor to examine and perform toxicological analyses of aqueous and benthic sediment samples from freshwater, estuarine and marine environments by County. Contractor shall perform all analyses according to published methods presented in the following documents or their subsequent updates:
Laboratory Procedures. No Police Department laboratory shall be used in the drug testing process. All laboratories must operate consistently within applicable State licensing requirements and be accredited by the Substance Abuse and Mental Health Services Administration (SAMHSA), College of American Pathologists (CAP), or comparable accreditation agencies. All laboratories shall be required to periodically participate in a proficiency rating program. The laboratories are expected to maintain appropriate internal quality control procedures.
Laboratory Procedures. The Contractor agrees that if applicable, network physicians will comply with CLIA requirements.
Laboratory Procedures. At the time field work was conducted in the various areas, bulk samples consisting of 2-15 kg of material, were processed to recover the heavy mineral assemblage. Although all samples were prepared in a similar manner, minor procedural changes occurred over the course of time. These changes involved the heavy mineral size fraction examined for KIMs and the specific gravity of the methylene iodide used to perform the heavy mineral separation. Processing of samples to recover XXXx reported on in this study was completed by Overburden Drilling Management (ODM) while the firm was under contract to the OGS. The laboratory procedure is discussed in detail by Xxxxxxx and XxXxxxxxxxx (1994). Procedural parameters that vary between the individual areas are listed in Table 1 and defined within Appendix B. Study Area Size Fraction Specific Gravity Picked <1.0 mm <1.7 mm 3.2 S.G. 3.3 S.G. Attiwapiskat/ Fort Albany X X Fort Xxxxxxx X X Michipicoten X X Separation Lake X X Sudbury Basin X X Swayze X X X West Bay X X West Xxxxxx River X X Table 1. Specific Gravities, grain size fractions used and analyzed for isolating kimberlite indicator minerals from samples in the various projects. Samples from the following areas were processed by passing the <1.7 mm fraction through a methylene iodide heavy liquid separation (S.G. 3.2): Michipicoten River area; Sudbury Basin; and those samples with a number between 92KDA-0 to 120, 00-0000-00 to 208, 00-0000-000 to 227 and 00-0000-000 to 257 from the Swayze greenstone belt area. The Attawapiskat- Fort Albany, Fort Xxxxxxx; Separation Lake, West Bay, Western Xxxxxx River areas and the remainder of the Swayze samples, were processed by passing only the <1.0 mm fraction through the methylene iodide heavy liquid separation (S.G. 3.2). ODM changed their procedure as the 1.0 to 1.7 mm grain size fraction yielded negligible amounts of kimberlite indicator minerals while analysis of this fraction can significantly increase cost (Remy Huneault; Overburden Drilling Management Limited, personal communication, 1995).
